• In the past two years, Align Technology reported annual revenue growth of only 2.3%, while rising expenses reduced its adjusted operating margin and returns on capital.
• Together, these trends highlight how intensifying competition is pressuring Align’s ability to convert its clear aligner leadership into improving profitability.
• Next, we’ll examine how slower revenue growth and margin pressure from competition reshape Align Technology’s existing investment narrative and assumptions.

AI is about to change healthcare. These 30 stocks are working on everything from early diagnostics to drug discovery. The best part - they are all under $10b in market cap - there's still time to get in early.

Align Technology Investment Narrative Recap

To own Align Technology, you need to believe its clear aligner and digital dentistry ecosystem can still convert clinical leadership into healthy, sustainable profitability, even as competition and macro pressures limit pricing and volume. The latest data showing only 2.3% annual revenue growth and lower returns on capital directly touches the biggest near term catalyst, improved margins, and reinforces the key risk that rising rivals are eroding Align’s ability to defend its premium economics.

The most relevant recent development here is Align’s full year 2026 outlook, which targets modest 3–4% revenue growth and a GAAP operating margin of about 18.0%. That guidance sits against the backdrop of slowing top line expansion and higher expenses, and it frames how much room there is for product innovation and cost control to offset ongoing competitive and macro headwinds in the clear aligner and scanner markets.

Yet beneath Align’s clear clinical brand strength, investors should be aware that rising competition and discounting may keep pressuring margins and returns on capital...

Align Technology's narrative projects $4.7 billion revenue and $726.5 million earnings by 2029. This requires 4.9% yearly revenue growth and about a $316 million earnings increase from $410.4 million today.

Uncover how Align Technology's forecasts yield a $201.69 fair value, a 23% upside to its current price.

Exploring Other Perspectives

Some of the lowest estimate analysts tell a much harsher story, with revenue growth of only about 3.4% a year and earnings of roughly US$670.7 million by 2029, reminding you that expectations around competition and margin pressure can differ widely and that this latest slowdown could still reshape those already cautious forecasts.

Explore 6 other fair value estimates on Align Technology - why the stock might be worth 5% less than the current price!

The Verdict Is Yours

Don't just follow the ticker - dig into the data and build a conviction that's truly your own.

• A great starting point for your Align Technology research is our analysis highlighting 3 key rewards and 1 important warning sign that could impact your investment decision.
• Our free Align Technology research report provides a comprehensive fundamental analysis summarized in a single visual - the Snowflake - making it easy to evaluate Align Technology's overall financial health at a glance.

Searching For A Fresh Perspective?

Our daily scans reveal stocks with breakout potential. Don't miss this chance:

• The latest GPUs need a type of rare earth metal called Terbium and there are only 28 companies in the world exploring or producing it. Find the list for free.
• The future of work is here. Discover the 32 top robotics and automation stocks leading the charge in AI-driven automation and industrial transformation.
• Uncover the next big thing with 27 elite penny stocks that balance risk and reward.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.